1. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced 
Avichai Shimoni, Moshe Yeshurun, Izhar Hardan, Abraham Avigdor, Isaac Ben-Bassat, Arnon Nagler 
Biology of Blood and Marrow Transplantation 
Volume 10, Issue 7, Pages (July 2004)
DOI: /j.bbmt

2. Figure 1
Cumulative incidence of thrombotic microangiopathy (TMA) after 147 allogeneic stem cell transplantations.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

3. Figure 2
Cumulative incidence of thrombotic microangiopathy (TMA) after 147 allogeneic stem cell transplantations and a comparison of the incidence among patients with a history of recent (<6 months) allogeneic or autologous stem cell transplantation and those with no recent transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

4. Figure 3
Overall survival after the diagnosis of thrombotic microangiopathy after allogeneic stem cell transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )